Golden Throat Holdings Group Company Limited (HKG:6896)

Market Cap	3.24B
Revenue (ttm)	1.26B
Net Income (ttm)	339.08M
Shares Out	739.30M
EPS (ttm)	0.46
PE Ratio	9.55
Forward PE	n/a
Dividend	0.50 (11.24%)
Ex-Dividend Date	Jun 16, 2025

Volume	719,100
Average Volume	995,091
Open	4.450
Previous Close	4.450
Day's Range	4.350 - 4.450
52-Week Range	2.900 - 5.650
Beta	0.26
RSI	36.58
Earnings Date	Aug 22, 2025

About HKG:6896

Golden Throat Holdings Group Company Limited, an investment holding company, manufactures and sells pharmaceutical, healthcare food, and other products in the People’s Republic of China and internationally. The company offers Golden Throat Lozenges, an over-the-counter medicine to relieve symptoms of sore and dry throat, and hoarse voice caused by acute pharyngitis. It also provides Golden Throat Lozenge series products, which include Dule Lozenges; sugar-free Dule Lozenges; and other sugar free flavours, such as orange, fructus momordicae, chr...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1956
• Employees: 874
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 6896

Financial Performance

In 2024, HKG:6896's revenue was 1.19 billion, an increase of 23.26% compared to the previous year's 961.38 million. Earnings were 318.63 million, an increase of 27.37%.

Financial numbers in CNY